A 7 kDa toxin isolated from the venom of the Texas coral snake (Micrurus tener tener) was subjected to collision-induced dissociation (CID) and electron-transfer dissociation (ETD) analyses both before and after reduction at low pH. Manual and automated approaches to de novo sequencing are compared in detail. Manual de novo sequencing utilizing the combination of high accuracy CID and ETD data and an acid-related cleavage yielded the N-terminal half of the sequence from the reduced species. The intact polypeptide, containing 3 disulfide bridges produced a series of unusual fragments in ion trap CID experiments: abundant internal amino acid losses were detected, and also one of the disulfide-linkage positions could be determined from fragments formed by the cleavage of two bonds. In addition, internal and c-type fragments were also observed.
Introduction
M ass spectrometry has become a significant player in peptide sequence determination approximately a quarter of a century ago [1, 2] . While the function of this technique has dramatically shifted towards high-throughput peptide identification utilizing the ever-expanding protein and genomic databases with automated search engines, mass spectrometry's role in de novo sequencing remains important. Quite a few automated search engines can compensate for a series of "problems" in identifying protein fragments such as nonspecific cleavages, misidentification of the monoisotopic mass, amino acid substitutions, and unexpected covalent modifications, but the combination thereof may still prevent correct identification of a peptide. In addition, even fully-sequenced genomes yield incomplete protein databases because translations are usually predicted based on similarities with other species; species-specific sequences may not overlap sufficiently with known proteins for accurate prediction and, thus, may be overlooked. Last but not least, we have very limited genomic (and therefore proteomic) information for a vast number of species.
Neuroscience frequently utilizes toxins as biochemical and pharmacologic tools that can be used to manipulate key physiologic receptors [3] . These toxins can be isolated from a wide variety of species, including sea snails, insects, fishes, centipedes, spiders, scorpions, lizards, and snakes. They represent a bewildering variety of structures and, in most instances, genomic information is lacking. Furthermore, unusual covalent modifications frequently occur. Thus, de novo sequencing is typically required for the characterization of these interesting and valuable polypeptides.
Most de novo sequencing programs were developed for (and work most reliably for) tryptic peptides [4] [5] [6] . Presently, the PEAKS de novo sequencing software is used most frequently. Most available software cannot interpret/ identify "atypical" fragmentation patterns very successfully. A new approach, composition-based sequencing (CBS), was developed to utilize the high mass accuracy of the precursor ions and some fragment masses for de novo sequencing. However, since the paradigm involves the determination of the amino acid composition of the entire peptide from a few per se unambiguous fragment ions, the method can only be used for relatively short sequences [7] .
Collisional activation of non-tryptic sequences may represent a significant challenge because of the unpredictable fragmentation pattern (most tryptic peptides feature a single basic residue at the C-terminus, which leads to preferential charge retention and abundant y ions). Thus, the CBS method could be more successful for such peptides. Another potential solution would be to apply two complementary activation methods: electroncapture or electron-transfer dissociation (ECD and ETD) and collision-induced dissociation (CID) for the analysis of each molecule. While the primary cleavage site in CID is the peptide bond, yielding b and y fragments, the bond between the amino group and the α carbon will fragment in ECD/ETD experiments producing mostly z . and c ions [8] . The combination of CID and ECD data has been reported for improved peptide identification [9] as well as for de novo sequencing [10] . Identification of complementary fragment ions in corresponding CID and ECD/ ETD spectra provides a strong framework for sequence determination, and high-accuracy mass measurements make these identifications more reliable. The mass accuracy afforded may be sufficient to apply the CBS paradigm for a single ion series and obtain unambiguous sequence assignments. Indeed, that is what we demonstrate in this paper.
In this study we describe a polypeptide, MitTxα purified from the venom of the Texas coral snake (Micrurus tener tener), that proved to be part of a heteromeric complex functioning as a selective agonist for acid-sensing ion channels [11] . MALDI mass measurement indicated a single, 7 kDa component in the fraction of interest. Thus, we set out to use different MS/MS techniques with high accuracy mass measurement to obtain sufficient sequence information either to identify the polypeptide (if it has been included in the public protein databases) or to provide suitable information for successful cloning experiments.
We will present how the combination of high accuracy ion trap CID and ETD data permitted sequencing of the Nterminal half of the molecule. We will show that de novo sequencing is still an area where human intervention is important for success. We will also show some unusual CID fragmentation for the intact polypeptide.
Experimental

Reduction/Alkylation Attempts
To aliquots of toxin solution in 25 mM ammonium bicarbonate buffer, pH~8, 15 nmol of DTT was added, and the mixture was incubated at 56°C for 30 min. Then 32 nmol of iodoacetamide or iodoacetic acid was added, and the mixture was incubated at room temperature for 30 min.
Successful Reduction of the Polypeptide
Toxin solution was incubated with 125 nmol of TCEP in 0.1% formic acid, at 37°C, for 24 h.
An aliquot of the mixture was analyzed on a Nano-ACQUITY (Waters)-LTQ-Orbitrap Velos LC/MS system in LC/MS mode in order to assess the success of reduction. For all LC/MS experiments solvents A and B were 0.1% formic acid in water or acetonitrile, respectively. Gradient elution from 5% to 40% B in 35 min was used to fractionate the components.
Peptide Fragmentation Analyses
MS/MS and MS
3 analyses of the intact polypeptide were performed with an infused solution (~400 nL/min) of the polypeptide, using an LTQ-Orbitrap XL with ETD or CID activation in the linear trap. Fragments were measured in the Orbitrap. The isolation window was 10 Th for both MS2 and MS3 experiments, and 2 microscans were acquired. ETD activation time was 30 ms. The CID activation energy was set at 35% and 40%, for the ETD-9CID and the CID experiments, respectively. AGC targets were set at 10 4 for the linear trap and 2×10 5 for the Orbitrap, which was operated at a resolution of 30,000.
MS/MS analysis of the short peptide was performed using an LTQ-Orbitrap Velos mass spectrometer; an aliquot of the TCEP-containing mixture was diluted with an equal amount of acetonitrile, and infused at a flow rate of~400 nL/ min. CID experiments on both the doubly and singly charged precursor ions were performed in the linear trap at a 35% normalized collision energy, while the fragments were measured in the Orbitrap. Higher-energy collisiondissociation (HCD) collision energy was also set to 35%. The precursor ion window was 2 Th, resolution was set to 30,000, and the AGC setting was as in the LC/MS/MS experiment below.
MS/MS analysis of the long peptide was performed using an LTQ-Orbitrap Velos mass spectrometer; the analysis was performed in LC/MS mode. Precursor as well as MS/MS fragment masses were measured in the Orbitrap, at a resolution of 30,000 and 15,000, respectively. The isolation width was set to 7 Th, the minimum peak intensity to trigger CID or ETD analysis was set to 2000. The AGC target for MS/MS experiment was set to 10 4 and 8×10 4 for the linear trap and the Orbitrap, respectively. Single microscans were acquired for CID at 35% normalized collision energy and for ETD at 37.5 ms activation time. The fluoranthene AGC target was 10 6 .
Data Processing
Scans representing the same MS/MS experiments were merged using the Xcalibur (ver. 2.1.0 build 1139) software. Peak lists were generated using Xtract as well as manually.
Xtract is a feature of Xcalibur, which converts the ions observed into a list of singly charged masses. The resolution afforded and the signal-to-noise ratio of the ions to be deconvoluted can be specified. These parameters are listed with the peak lists presented.
De novo sequencing was performed manually as presented below.
MS-Product and MS-Comp of Protein Prospector ver. 5.8.0 (www.prospector.ucsf.edu) was used to display instrument-specific fragmentation and potential amino acid compositions, respectively. PEAKS Studio 5.3 build 20110719 was also tested for de novo sequencing [6] .
Spectra were also evaluated using in-house software FAVA, which performs peak-picking using the sequence determined [12] .
Results and Discussion
A toxin-containing fraction named MitTxα from the venom of the Texas coral snake (Micrurus tener tener) [11] was subjected to mass spectrometry analysis via infusion in an LTQ-Orbitrap. The polypeptide's monoisotopic mass was determined from ions at m/z 888.3915(8+), 1015.1630(7+), 1184.1883(6+), and 1420.8202(5+) as 7100.0830 (MH + ). The toxin molecule seemed to be both sufficiently small and sufficiently charged for ETD analysis. Unfortunately, the ETD analysis of m/z 1015(7+) (the 8+ ion was not abundant enough) yielded no information besides the charge reduced ions (Data not shown).
Considering that sometimes fragmentation occurs, but the newly formed ions are kept together by electrostatic interactions or hydrogen-bridges, an MS3 experiment was performed: first m/z 1015(7+) was subjected to ETD activation, and then the most abundant charge-reduced ion m/z 1422(5+) was subjected to CID analysis (Figure 1) . Only a few abundant fragments were detected. The mass differences observed in the first ion cluster were 31.9719 Da (1204-1172) and (1238-1206), and 33.9881 Da (1206-1172) and (1238-1204). The theoretical mass for S is 31.9720 and for H 2 S is 33.9877, and so the observed mass differences are the signature of an intermolecular disulfide linkage and correspond to cleavages across the disulfide bridge [13] . Since the other abundant fragment at m/z 1474.89(4+) corresponds to the 'missing' part of the molecule, these data suggested the presence of a disulfidebound heterodimer.
Disulfide-bridges in toxins are rather common. Thus, we proceeded with reduction/alkylation of the molecule following a general protocol with DTT and iodoacetamide. This reaction, attempted multiple times, led to complete sample loss. First we suspected solubility problems as a result of carbamidomethylation, and also experimented with iodoacetic acid with the same negative results. Oxidation of the disulfides was an option that we discarded, since the introduction of negatively charged groups (i.e., cysteic acids) would be unlikely to improve the charge density and ETD efficiency.
We decided to keep the peptide in an acidic solution (0.1% formic acid in water) resembling that which was used for its purification and performed the reduction at low pH with TCEP. Extended reaction time, elevated temperature, and larger than usual reagent excess was used in order to achieve complete reduction. The results were somewhat surprising. The smaller peptide (MH + =1224.5352) was analyzed first from the infused reaction mixture. Sequencing this peptide was relatively straightforward; we had good quality CID and HCD data for both the doubly and singly charged precursor ions, with the latter ones being more informative for de novo sequencing ( Figure 3 ). We started with the CID data, since it was expected that both N-terminal and Cterminal ions would be present, while b-type fragments frequently do not survive the multiple collisions occurring during HCD activation (Nomenclature: [14] ). The very abundant ion triplet at m/z 1063, 1091, and 1109 was readily identified as a n-1 , b n-1 , and b n-1 +H 2 O (where n=the number of residues in the peptide) revealing that the Cterminal residue must be Asp (1224-1109=115) and also suggesting that there must be a basic residue somewhere in the sequence because such rearrangement has been reported for peptides with preferential charge retention at the Nterminus [15, 16] . The other a-b fragment pairs could be easily identified downstream at m/z 934 and 962, 771 and 799, 668 and 696, 521 and 549, identifying Glu, Tyr, Cys, and Phe, respectively. Interestingly and unexpectedly, internal ions were also detected in the CID spectrum, m/z 582 and 554, that were separated by 28 Da as well, but luckily ions belonging to the b ion series also featured an ammonia loss and were therefore distinguishable. Thus, the sequence could be tentatively determined at this point to be …FCYED. However, the clues fizzled out here, and we had to turn to the more complex HCD data to proceed ( Figure 3 , lower panel). From there the next a-b pair was identified at m/z 353 and 381 (the latter was also detected in the CID data). The 168 Da gap between this b fragment and the previously identified b at m/z 549 could only correspond to a Pro-Ala combination. Since Pro residues usually produce an abundant y fragment, it was easy to determine that these amino acids are indeed present and that they appear in this order. Hence, m/z 478 (and the highly abundant m/z 461 ion that represents an ammonia loss) could be unambiguously identified as the "missing" b-fragment, while the y fragment formed via cleavage at the N-terminal side of Pro is at m/z 844, and our working sequence is now …PAFCYED. Considering internal fragments from this sequence helps to assign numerous ions in the low mass region, such as m/z 169 and 141 (PA and PA-28), 316 and 288 (PAF and PAF-28), 267 and 239 (CY and CY-28) etc. (for a complete list, see Table 1 ). At the same time, we believe that there must be a basic amino acid in the sequence, and from low mass ions at m/z 112 and 115, one suspects an Arg [17] . Indeed, there is an a-b pair at m/z 197 and 225, indicating that the next residue towards the N-terminus is an Arg. However, according to the 'MS-Comp' feature of Protein Prospector, there is no amino acid combination that would yield a b fragment at this mass, even if we permit a 50 ppm mass measurement error, which is much higher than our instrument actually affords. However, if a common N-terminal modification, the cyclization of Gln residue, is considered, the fragment is within 2 ppm for b 2 of G Gln[Ile/Leu] (Nterminal acetylation was also considered and checked).
Thus, the final sequence of the short peptide is G Gln-[Ile/ Leu]-Arg-Pro-Ala-Phe-Cys-Tyr-Glu-Asp. Fragments calculated by 'MS-Product'of Protein Prospector for ESI-Q-TOF instrument selection (which also corresponds to HCD fragmentation) and fragments observed are listed in Table 1 , along with the errors in mass measurement.
We tested the most popular sequencing program, PEAKS, de novo with this spectrum. The raw data were loaded, the precursor ion m/z value was manually corrected, and the spectrum was processed by the program. For de novo sequencing, no enzyme was specified, and the mass accuracies considered were 5 ppm and 0.02 Da for the precursor and fragments, respectively (relative mass accuracy cannot be specified for fragments). After a series of failed attempts, we realized that instrument selection was critical, as the software had to recognize the data as 'high energy CID' fragmentation in order to determine sequences (even though this definition is not correct). From this experience, we arrived at the same conclusion as the 2011 ABRF iPRG study: being highly familiar with the software produces much better results [18] . When ion trap CID was considered, the abundant internal fragments proved sufficient to trip the algorithm. Q-TOF, Q-FT, and FTMS instrument selection yielded the correct sequence (obviously only if the software was informed about the possibility of blocked terminus, (i.e., N-acetylation or pyroglutamate formation were permitted). However, less than 10% confidence was attached when the first two instruments were specified. With the FTMS instrument selection, the following sequence was determined with 90% confidence: ions and internal fragments only during the third step, while reevaluating the 10,000 best candidates [6] . The first premise is not necessarily true for non-tryptic sequences, as illustrated with the abundant N-terminal ions of this peptide and, we believe, this fact definitely contributed to the low confidence of the sequence determination. At the same time, we cannot tell which internal fragments were identified and used by the algorithm: the fragment labeling option included the internal fragments as default, however, these ions were not assigned by the software. Strangely, only m/z 112 and 169 were indicated, both incorrectly as PAFCY-28. The confidence difference between the assignments is also puzzling, since data processing with each instrument-type yielded 93 identical masses (judging from the mass accuracy charts accompanying each assignment).
Next, we turned to analyzing the larger (MH + = 5900.6184) peptide that was observed after reduction of the toxin. While the short peptide gave good quality data upon direct infusion of the reaction mixture, the longer sequence had to be analyzed by LC/MS/MS analysis. The precursor ion selection was restricted, and alternating CID and ETD data were acquired from m/z 738(8+). Both activation steps were performed in the linear trap, and the fragments were measured in the Orbitrap.
CID spectra and ETD spectra between 38.5 and 39 min (representing the apex of the eluting peak), were merged starting around 50% XIC intensity and were used for partial de novo sequencing (spectra are shown in Supplementary  Tables 1 and 2 ). Monoisotopic masses and charge states were determined manually and inserted into an Excel Tables 1 and 2; and Table 2 represents a combined, concise version). We compared the manual peakpicking with that of the deconvolution program, Xtract, supplied by the manufacturer. Because of the overlapping multiply-charged peaks and weak or absent monoisotopic ions, neither solution was entirely satisfactory (Supplementary  Tables 3-5) . We found that the Xtract program tends to overlook or misassign some singly-charged ions (see Supplementary Table 3 ), but otherwise the greatest difficulties are caused by overlapping fragment ions. In general, for large multiply-charged ions, both "eyeballing" and modeling based on the "averagine" peptide composition work equally well, but not completely reliably. The manually-generated peak list may not be as complete as the software-generated one, but it contained all of the important singly-charged ions and was definitely more reliable for de novo sequencing. This was especially true for the information-rich CID data. In the Excel workbook, the singly-charged accurate masses were calculated from the monoisotopic masses and charges using the formula m/z*z-(z-1)*1.007825. Then, the fragment masses were sorted. Since members of the ion series usually cannot be identified per se, a series of other masses were calculated using the observed masses as reference points. In the CID Table (Table 2,  Supplementary Table 1 ) the nominal masses of the corresponding complementary ions (y fragment for b and vice versa) were calculated using the formula b i +y n-I =MH + + 1. In the ETD Table (Table 2, Supplementary Table 2 consisting of a His and a Gly, while m/z 212 is c 2 corresponding to ProPro. These assignments are unambiguous because these were the only potential structures within 5 ppm (according to the MS comp feature of Protein Prospector). Based on the ETD data, a series of b fragments could be identified in the CID spectrum, and so the sequence was built from the N-terminus. First, two Phe residues were added to the sequence, but these were followed by a 256.155 gap that could be filled by either an {Ala, Gly, Lys} or a {Gln, Lys} combination. Obviously, an Ala, Gly combination would yield the very same 'c' fragment as the Gln. We discarded this option for the lack of any supporting ions in the CID. Based on this information, the c fragment at m/z 634 was considered, which, due to the afforded mass accuracy, identifies a Gln in position-5 and, consequently, a Lys in position-6. Interestingly, this 'c' fragment was also detected in the CID spectrum, as will be discussed later.
Assuming that m/z 865 in the ETD peak list was a c fragment, the next residue was identified as Cys, and the following cfragments, originally assigned based on the corresponding bions in CID, determined that Gly, Ala, and Phe are the next The peptide sequence was determined from these data as G QL/IRPAFCYED. In the CID spectrum, the unexpected internal fragments are labeled, while some of the abundant fragments were assigned in the HCD spectrum. Annotation open circle (O) indicates ammonia loss. Otherwise, the Biemann nomenclature was applied [14] . For complete fragment assignment, see Table 1 . The base peak in the CID spectrum featured an intensity~3000, while in HCD~6000 three residues. Thus, our working sequence at this point is ProProPhePheGlnLysCysGlyAlaPhe. The CID data did not help for the next two residues, but c ions detected in the ETD spectrum determined them to be Val and Asp. The next three residues were assigned as SerTyrTyr in a similar manner. This step also identified m/z 1621 as a potential y fragment because it was present in both datasets and does not belong to the N-terminal series. By the same logic, the CID fragment at m/z 1735 must be also a y fragment. Following the clues provided by the ETD data, considering amino acid mass differences, and taking advantage of the mass accuracy, we could confidently determine the N-terminal sequence as PPFFQKCGAFVDSYYFNRS. The CID data provided an additional non-adjacent sequence stretch, which was determined as HFFYGQCDV. Just as the c ions in the ETD spectrum provided information for the N-terminal amino acids, the first six residues were identified from consecutive b fragments. The last b fragment (m/z 3606) could then be tied to a series of y ions. The complementary y fragment at m/z 2295 was the first in this series, and m/z 1977 identified by ETD data was the last. (Table 2 , Supplementary Tables 1 and 2 ). The y fragment identifying the Val residue (m/z 2077) was detected in two different charge states, and the ETD data excluded it from the b-series. The 218 Da gap between this mass and m/z 2295 may correspond to three different amino acid combinations: AlaPhe, SerMet, and CysAsp, and the latter one was supported by a y fragment detected.
Since the ETD spectrum provided a string of c-fragments, c 2 -c 18 , each measured within 5 ppm, one would expect that a computer program could have easily determined the Nterminal sequence. Thus, the raw data were loaded into the PEAKS software with the FTMS(etd) instrument selection. We experimented with different mass accuracy windows from 0.005 to 0.1 Da, and in one trial also permitted methionine oxidation. All attempts yielded the correct Nterminal sequence, but unfortunately very little confidence was attached to it. The most confident assignment was: PPFFQKCGAFVDSYYFNRSCTCGWLMVTGPCHGRN-FYYSDVFAGCKGSMTRV, where the amino acids in bold were assigned with a confidence higher than 60%, and those in both bold and italic indicate higher than 90% confidence level. The mass error permitted for this assignment was 0.1 Da. Notably, the underlined sequences are identical to one another, but in reverse order. As it happens, while m/z 359 could still be identified unambiguously as a c fragment (within 5 ppm), all the other N-terminal fragments could 'double' as z . ions. Thus, it is clear that the supporting information from the CID data was essential to decide the position and correct order of the amino acids. In addition, when PEAKS software was used to search the CID data with 'ion trap CID' selected, it did not yield even a sequence tag. However, when the Orbitrap/Orbitrap combination was selected, the HFFYG internal sequence was confidently identified. Interestingly, although this spectrum represented ion trap CID data, the number of peaks and masses seemed to be the same after peak-picking for both instrument selections (the same parameters were used for both searches).
Since the short peptide featured a C-terminal Asp, while the longer peptide had a Pro at its N-terminus, it was now easy to explain the 18 Da mass discrepancy between the expected and observed mass of the shorter peptide after reduction. Instead of a disulfide-bound heterodimer, the toxin consists of a single chain that experienced a double cleavage event in the MS3 experiment. It is possible that first the disulfide-bridge was broken by ETD [19] , and then CID activation induced the Asp-Pro peptide-bond cleavage. However, there is another fragmentation pathway one has to consider: a smaller peptide population that survived the ETD activation intact underwent a double cleavage upon collisional activation. The fragmentation-prone Asp-Pro bond could have been broken first, and then fragmentation could have occurred along the disulfide bridge. Only this second sequence of events explains the characteristic ion-triplets that were observed. The Asp-Pro bond is acid-sensitive and must have hydrolyzed during the extended reduction at low pH, producing two individual peptides.
Finding sequence similarity among known proteins frequently serves as confirmation of sequences determined de novo. A BLAST search was performed using the N-terminal sequence stretch (QLRPAFCYEDPPFFQKCGAFVD-SYYFNRS), which did not yield any significant hits. Thus, the full sequence and the protein family to which our toxin belongs was determined by cloning the toxin-encoding cDNA using degenerate oligonucleotide-probes representing the 10 Nterminal residues of the longer peptide, as described earlier [11] . QIRPAFCYEDPPFFQKCGAFVDSYYFNRSRITCVHF-FYGQCDVNQNHFTTMSECNRVCG, the final sequence, matched the experimentally determined molecular mass perfectly, after adjustment for the N-terminal pyroglutamic acid and three disulfide bridges. A BLAST search with the complete sequence categorized this polypeptide as a Kunitz-type protein, showing 40% sequence identity to its closest relative up to date, Vestiginin-3, of Demansia vestigiata (Black whip snake) and complete conservation of the six Cys residues [11] .
Once the full sequence was determined, we re-evaluated the CID and ETD data of the longer sequence. Manual inspection of the ETD data provided some additional information in the form of Cys-specific 'w'-type fragment ions, which are formed from z . fragments via side-chain losses, a phenomenon reported for alkylated Cys-residues in ECD [20] . While the observation of these fragments was not unexpected, the detection of a series of potential b+2H ions is most unusual and awaits explanation (Supplementary Table 2 ). We also used a sequence-based peak-picking software to test the information content of both the CID and ETD spectra [12] . Since the peak-picking of this software is based on the expected theoretical ion clusters calculated not from averagine but from real elemental composition, it can identify the fragment ions even from overlapping isotope clusters. While this approach did not make any difference for this particular ETD data (Supplementary Table 4) , the CID spectrum contained substantially more information than either the manually prepared or Xtract-based peak lists revealed (Supplementary Table 3 ). Thus, as final confirmation a program utilizing the calculated masses and isotope distributions based on the sequence determined-as FAVA does-can reveal a wealth of supporting information still "hidden" in the spectrum, or may help to decide between different isobaric options.
While ETD analysis of the non-reduced peptide yielded very limited information even after CID activation of a charge-reduced ion (Figure 1) as discussed above, the polypeptide underwent significant fragmentation upon collisional activation that can be deciphered using the known sequence (Figure 4a and b, Supplementary Table 5 ). (Figure 2, upper panel) . Sample solution was infused, CID activation was performed in the ion trap, and fragments were measured in the Orbitrap. Open circle (o) indicates ammonia loss. * Indicates that the fragment contains a dehydroAla instead of the Cys. ** Indicates that the Asp-Pro linkage was cleaved and the N-terminal peptide is linked to the C-terminal fragment with a disulfide-bridge (i.e., Cys-7 and Cys-58 are linked). ❖indicates 'c' type internal fragment formation in front of Gln and Lys. Fragments 'S' and 'L' correspond to the short and long sequence when both the Asp-Pro linkage and the disulfide-bridge were broken. The subscript indicates that both sulfurs were retained on the fragment. Double bond cleavages and amino acid losses were observed as indicated from both the intact molecule and the larger fragment. For complete peak list and assignments, see Supplementary Table 5 Because of the disulfide-bridges and the positions of the Cys-residues (residue 7 is the first Cys residue, and the last is in the 58 th position) only six N-terminal and two Cterminal residues are outside of the cross-linked structure. Thus, very few fragments can be formed via single bond cleavages. Indeed, 'regular' fragmentation was only detected from the N-terminal part. Interestingly, the position of one of the disulfide-bridges could be determined because of the favored fragmentation at the Asp-Pro linkage. Fragments y 3 -y 5 were detected with a 1203 Da shift, that indicates linkage between Cys-7 and Cys-58, since the mass increment corresponds to the N-terminal 10 amino acids linked to the C-terminal fragments. We assume that first the Asp-Pro bond most prone to fragmentation was cleaved, but this cleavage product has the very same molecular mass as the original precursor ion and thus was further activated (just like described above for the MS3 experiment). This could explain all the internal fragments as well as the internal amino acid losses from the intact molecular ion.
This CID spectrum also features two c-type internal fragments, formed in front of Gln and Lys residues. It has been published that abundant c 1 ions can be observed in sequences in which the second residue is a Gln and for which the activation was performed in a collision cell [21] . The authors suggested that the c ions were formed from the b fragment corresponding to the next amino acid via the loss of a six-membered ring. Such ring formation is also possible for Ser, Arg, His, and Lys residues, based on thermodynamic calculations [22] . Thus, the observed c ion in front of the Gln and Lys residues can be produced via the same mechanism. The very same c fragments as well as c 29 were also detected in the CID of the bigger reduced peptide (Supplementary Table 1 ). This is the first time that such ion formation is reported for Lys residues, for higher sequence positions, and in ion trap CID experiments.
Conclusions
Even the most popular de novo sequencing program has difficulties assigning sequences from unusual or incomplete fragmentation patterns. Sequence-specific fragments, such as in our case the C-terminal a, b, b+H 2 O triplet, which significantly aid manual sequence determination, frequently prove to be the undoing of the automated approach. In addition, reliable peak-picking/deconvolution from a complex spectrum is still a challenging task as illustrated with our high quality data. When peptide identification is the goal, these obstacles are easier to overcome than when a novel sequence has to be determined. Recently, numerous groups have started to advocate de novo sequencing instead of comparative database searching [23] . While the software available seems to function well for ion trap data and for tryptic peptides, researchers aiming at developing such programs also should consider the wide-variety of sequenceor residue-specific fragmentation, which may provide important clues but remain not only underutilized, but rather completely ignored as insignificant. We would not recommend to incorporate such fragment ions into the search algorithm, but they could be (and should be) used to confirm the determined sequence and/or aid in the selection between similarly scoring alternatives. Furthermore, the recent surge in commercially available instruments that can measure precursor as well as fragment ions with a few ppm mass accuracy should force search engines to take advantage of this, since the results may not be reliable enough when only absolute mass accuracy can be specified.
